To make provision for the approval of the adoption in Hong Kong of a pharmacopoeia and for the admission in evidence of copies thereof.
(Amended 60 of 2000 s. 3)
[22 August 1958]
(Format changes—E.R. 3 of 2018)
This Ordinance may be cited as the Pharmacopoeia Ordinance.
The Medical Council of Hong Kong as established by section 3 of the Medical Registration Ordinance (Cap. 161), shall have the exclusive right of approving the adoption in Hong Kong of a pharmacopoeia containing descriptions of and standards for, and notes and other matter relating to, medicines, preparations, materials and articles used in the practice of medicine, surgery, or midwifery, and shall further have the exclusive right of approving the adoption of any amendments thereto.
(Amended 60 of 2000 s. 3)
A pharmacopoeia approved under section 2 shall be deemed for all purposes to be substituted in Hong Kong for all other pharmacopoeias; and any enactment or custom relating to any of such last-mentioned pharmacopoeias shall be deemed, after approval of a pharmacopoeia under section 2, to refer to such pharmacopoeia and any amendments thereto which have been approved.
(Amended 60 of 2000 s. 3)
Notice shall be published in the Gazette of any approval given under section 2 and of any amendment thereto and a copy of the pharmacopoeia or of any amendment thereto of which such notice of approval has been given, being a copy purporting to be printed by such printer as may be named in such notice, shall be received in evidence as such pharmacopoeia or amendment, as the case may be.